
Jan 22 (Reuters) - Johnson & Johnson JNJ.N:
J&J EXEC SAYS CONTINUES TO EXPECT CHINA TO REMAIN A HEADWIND THROUGH 2025 FOR ITS MEDICAL DEVICE BUSINESS - CONF CALL
J&J EXEC SAYS CO EXPECTS HIGHER EARNINGS PER SHARE GROWTH IN THE SECOND HALF OF 2025 VERSUS THE FIRST HALF
Further company coverage: JNJ.N
((Reuters.Briefs@thomsonreuters.com;))